Pharmaceutical Drugs Coverage

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Anti-Hypertensive Drugs Market Overview

• Anti-Hypertensive Drugs market size has reached to $37.42 billion in 2024 • Expected to grow to $40.74 billion in 2029 at a compound annual growth rate (CAGR) of 1.7% • Growth Driver: Sedentary Lifestyle And The Rising Demand For Anti-Hypertensive Drugs • Market Trend: Innovative Advancements In The Anti-Hypertensive Drugs Market • North America was the largest region in 2024 and Middle East is the fastest growing region.

What Is Covered Under Anti-Hypertensive Drugs Market?

Anti-hypertensive drugs refer to a group of medications used to treat high blood pressure (high blood pressure). The goal of antihypertensive therapy is to prevent the negative effects of high blood pressure, such as myocardial infarction and stroke. The main therapeutics of anti-hypertensive drugs are diuretics, angiotensin receptor blockers (ARBs), angiotensin-converting enzyme (ACE) inhibitors, beta-blockers, alpha-blockers, calcium channel blockers, renin inhibitors, and vasodilators. Diuretics, also known as water pills, are medications that increase the amount of water and salt excreted by the body in the form of urine. The various sources of diseases include primary hypertension and secondary hypertension, which are treated in hospitals, clinics, and at home care.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Acne Drugs Market?

Acne drugs refer to medications that aid in the treatment of acne scarring, blackheads, whiteheads, and other more severe types of the condition. It functions either by treating bacterial infections or by lowering edema and oil production. Usually, IT takes four to eight weeks before prescription acne medications start to work. Your acne might not go away completely for several months or even years. The main types of acne drugs are inflammatory acne drugs and non-inflammatory acne drugs. Inflammatory acne drugs refer to the drugs that are used to treat inflammatory acne problems such as mild to moderate inflammatory acne. The various therapeutic classes include retinoids, antibiotics, salicylic acid, and benzoyl peroxide which are used by various end-users such as hospitals and clinics, pharmacies and drug stores, and ambulatory surgical centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Dermatitis Market Overview

• Dermatitis market size has reached to $6.78 billion in 2024 • Expected to grow to $8.5 billion in 2029 at a compound annual growth rate (CAGR) of 4.8% • Growth Driver: Dermatitis Market Growth Fueled By Increasing Disease Prevalence And Food Allergies • Market Trend: Expanding Dermatitis Market Through Strategic Mergers And Acquisitions • North America was the largest region in 2024 and Middle East is the fastest growing region.

What Is Covered Under Dermatitis Market?

Dermatitis refers to the inhibitors that treat skin inflammation, which is characterized by itchy rashes on swollen and reddish skin in the outer layer of the body. It is a general term that describes a common skin irritation. The main classes of drugs in dermatitis are corticosteroids, emollients/moisturizers, antihistamines, calcineurin inhibitors, Antibiotics, immunomodulators, and interleukin inhibitors. Corticosteroids are a group of steroid hormones generated by vertebrates' adrenal cortex and are also synthetic equivalents of these hormones. The different routes of administration include topical, oral, and injectable and are used in cancer, blood disorders, chronic diseases, and infectious diseases. It is distributed through various channels such as hospitals, retail pharmacies, drug stores, and online or mail pharmacies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Psoriasis Market Overview

• Psoriasis market size has reached to $26.45 billion in 2024 • Expected to grow to $40.93 billion in 2029 at a compound annual growth rate (CAGR) of 9.1% • Growth Driver: Prevalence Of Psoriasis Driving Market Growth • Market Trend: Combination Therapy Is An Emerging Trend In The Psoriasis Market • North America was the largest region in 2024 and Middle East is the fastest growing region.

What Is Covered Under Psoriasis Market?

Psoriasis refers to a skin condition that typically affects the knees, elbows, trunk, and scalp and results with a rash with itchy, scaly spots. The primary contributing factor may be an immune system issue wherein infection-fighting cells unintentionally kill healthy skin cells. The main classes of drugs in psoriasis are interleukin inhibitors, corticosteroids, Anti-Inflammatory, and tumor necrosis factor inhibitors. Corticosteroids are a group of steroid hormones generated by vertebrates' adrenal cortex and are also synthetic equivalents of these hormones. The different types of drugs include small molecules and biologics and involve various disease indications such as plaque psoriasis, nail psoriasis, guttate psoriasis, pustular psoriasis, and erythrodermic psoriasis. The several routes of administration include oral, topical, injectable, and distributed through hospitals, retail pharmacies, and e-commerce.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Antacids Market Overview

• Antacids market size has reached to $9.63 billion in 2024 • Expected to grow to $11.18 billion in 2029 at a compound annual growth rate (CAGR) of 3% • Growth Driver: Rising Incidence Of Acidity Due To Unhealthy Lifestyles Boosts Antacids Market • Market Trend: Mouth-Melting Antacids Revolutionize The Market • North America was the largest region in 2024 and Middle East is the fastest growing region.

What Is Covered Under Antacids Market?

The antacids drugs refer to the drugs that are used to neutralize stomach acid, and treat acid reflux, heartburn, and indigestion. Antacids are medications that counteract (neutralize) your stomach's acid to ease heartburn and indigestion. They are available without a prescription from pharmacies and stores and come in liquid or chewable tablet form. It includes drug classes such as proton pump inhibitors, H2 antagonists, surgical simulators, and acid neutralizers in the form of tablets, liquid, or powder. The main classes of antacids are proton pump inhibitors, H2 antagonists, acid neutralizers, and pro-motility agents. Proton-pump inhibitors are a type of drug that reduces stomach acid production significantly and for a long time. They accomplish this by blocking the H+/K+ ATPase proton pump in the stomach in an irreversible manner. The different types of formulations include tablets, liquids, powders, and others and are distributed through various channels such as hospital pharmacies, retail pharmacies, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Hypolipidemics Market Overview

• Hypolipidemics market size has reached to $30.72 billion in 2024 • Expected to grow to $35.99 billion in 2029 at a compound annual growth rate (CAGR) of 3.1% • Growth Driver: Changes In Diet And Lifestyle Are Driving The Hypolipidemic Drugs Market • Market Trend: Wearable Technologies In Clinical Trials • North America was the largest region in 2024 and The Middle East is the fastest growing region.

What Is Covered Under Hypolipidemics Market?

Hypolipidemic drugs refer to any substance that lowers the blood's concentration of lipids and lipoproteins (lipid-protein complexes). Lipoproteins can build up in blood arteries and bind cholesterol. Its alternate name is lipid-lowering medication. The main product types of hypolipidemic drugs are cholic acid regulators, HMG-CoA reductase inhibitors, adenylate cyclase inhibitors, nicotinic acid drugs, and others. HMG-CoA reductase inhibitors are lipid-lowering drugs used in the primary and secondary prevention of coronary heart disease. The drugs are used by hospitals, clinics, pharmacies, and cardiovasology. The different types of drugs include statins, bile acid sequestrants, cholesterol absorption inhibitors, PCSK9 inhibitors, and others.